{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:55:00Z","timestamp":1778824500979,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jcin.2014.11.010","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T21:45:30Z","timestamp":1421790330000},"page":"198-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"PB","title":["Bioresorbable Drug-Eluting Stents"],"prefix":"10.1016","volume":"8","author":[{"given":"Robert A.","family":"Byrne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2014.11.010_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","article-title":"Bioresorbable scaffolds: rationale, current status, challenges, and future","volume":"35","author":"Iqbal","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2014.11.010_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(13)62240-0","article-title":"Drug-eluting stent trials: too much non-inferiority, too little progress?","volume":"383","author":"Byrne","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2014.11.010_bib3","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes\u00a0from the European multicentre GHOST-EU registry","author":"Capodanno","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2014.11.010_bib4","article-title":"Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry","author":"Kraak","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2014.11.010_bib5","article-title":"Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios","author":"Jaguszewski","year":"2014","journal-title":"Clin Res\u00a0Cardiol"},{"key":"10.1016\/j.jcin.2014.11.010_bib6","author":"Serruys","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2014.11.010_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcin.2014.10.005","volume":"8","author":"Brugaletta","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2014.11.010_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000201273","article-title":"Patterns of presentation and outcomes of patients with acute coronary syndromes","volume":"113","author":"Ndrepepa","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jcin.2014.11.010_bib9","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2014.11.010_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4244\/EIJV10I6A130","article-title":"Tools & techniques\u2014statistics: propensity score techniques","volume":"10","author":"da Costa","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2014.11.010_bib11","unstructured":"ClinicalTrials.gov. ABSORB STEMI: the TROFI II study. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01986803. Accessed December 2,\u00a02014."},{"key":"10.1016\/j.jcin.2014.11.010_bib12","unstructured":"ClinicalTrials.gov. A prospective, randomized trial of BVS veruss EES in patients undergoing coronary stenting for myocardial infarction (ISAR-Absorb MI). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01942070. Accessed December 2,\u00a02014."},{"key":"10.1016\/j.jcin.2014.11.010_bib13","unstructured":"Schulz-Sch\u00fcpke S. Six versus twelve months of clopidogrel therapy after drug-eluting stenting\u2013the randomized, double-blind, placebo-controlled ISAR-SAFE trial. Paper presented at: American Heart Association Scientific Sessions; November 15 to 19, 2014; Chicago, IL."},{"key":"10.1016\/j.jcin.2014.11.010_bib14","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or\u00a030 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N\u00a0Engl J Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879814015982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879814015982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T05:54:10Z","timestamp":1537941250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879814015982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1936879814015982"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2014.11.010","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioresorbable Drug-Eluting Stents","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2014.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2014.10.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}